NASDAQ: GILD · Health Technology
Which UK funds hold Gilead Sciences, Inc. (GILD)?
Gilead Sciences, Inc. (GILD) is among the ten largest holdings of 13 UK funds Fundology covers, according to the holdings each fund publishes. In the largest of these funds by size, it makes up 3.03% of IHCU (iShares S&P 500 Health Care Sector UCITS ETF), 8.41% of BTEK (iShares NASDAQ US Biotechnology UCITS ETF) and 2.95% of XSHC (Xtrackers MSCI USA Health Care UCITS ETF). The largest weight is 8.42%, in SBIX (Invesco NASDAQ Biotech UCITS ETF), as of 08/10/2026. In all, 205 funds list it among their published holdings. 67 swap-based funds also list Gilead Sciences, Inc. (GILD) in the substitute baskets they hold as collateral; they track different indices through swaps and are not counted as holders.
UK funds that hold Gilead Sciences, Inc.
Funds where it is one of the ten largest holdings, largest weight first. A weight is the share of the fund’s money in this company.
Source: fund issuers’ published holdings, dates differ by fund
Funds that hold it further down
192 more funds list Gilead Sciences, Inc. below their ten largest holdings.
Create a free account to see every fund that holds this company, at any weight
Sign-up takes an email address. There is no card to enter and nothing to pay.
About Gilead Sciences, Inc.
Gilead Sciences, Inc. is listed on NASDAQ under the symbol GILD, in the health technology sector as TradingView classifies it. Its market value was about $193.7bn (in US dollars) on 16/10/2026.
A fund’s weight in a company is the share of the fund’s money held in that company’s shares. A weight of 5% in a fund worth £1 billion is about £50 million. Index funds hold companies in proportion to their size in the index, so the largest companies appear in many funds at similar weights.
The list above comes from holdings the fund issuers publish, each dated, and names the funds where Gilead Sciences, Inc. is one of the ten largest holdings — the part of every fund page open to anyone. Some issuers publish only their largest ten, so a fund can hold Gilead Sciences, Inc. without it appearing in any list here. When two funds both hold the same large companies, owning both can be closer to owning one than it looks: the comparison page measures that overlap when both funds publish enough of their holdings.
Share price
- Latest price
- $156.19
- −0.75%on the day
- 52-week range
- $114.02–$160.51
- Price change, 1 year
- +32.4%
- Price change, this year
- +27.5%
- Market value
- $193.7bn
Source: TradingView, as of , at least 15 min delayed